SEARCH RESULTS FOR: Angioedema-Bradykinin-Mediated

Angioedema Bradykinin Mediated

Angioedema – Bradykinin Mediated: Pathogenesis and clinical findings
   Drug Induced
Angiotensin converting enzyme inhibitor, dipeptidyl peptidase-4 inhibitor, or neprilysin inhibitor use
Hereditary
Type II
Acquired
          Thrombolytic use
Activate factor XII
Factor XII initiates bradykinin synthesis
Type I
Type III
Gain of function gene mutation in bradykinin cascade activators (factor XII) & precursors (kininogen), triggered by ↑ systemic estrogen
Rheumatologic disorders & B- cell lymphoproliferative disease
Complement cascade activation results in ↑ C1 protease production
C1 esterase inhibitor is utilized to neutralize C1 protease, with its consumption exceeding its synthesis
Plasma cell proliferation (i.e., dyscrasia/ monoclonal gammopathy)
Immunoglobulin G antibodies act against C1 esterase inhibitor to render it non-functional
 Genetic or spontaneous mutation in C1 esterase inhibitor gene
       C1 esterase inhibitor deficiency
C1 esterase inhibitor dysfunction
       Inhibition of angiotensin converting enzyme, dipeptidyl peptidase-4, or neprilysin induced metabolism of bradykinin
↓ Bradykinin (peptide hormone) degradation in plasma
Misfunctioning C1 esterase inhibiter is unable to inactivate bradykinin cascade members
↓ C1 esterase inhibiter results in inadequate inactivation of bradykinin cascade members
      ↑ Bradykinin protein production in plasma
Cutaneous Tissue
Mucosal Tissue
Epidermal layer
 Dermal-Epidermal Junction
  Dermal layer
Subcutaneous layer
    Systemic bradykinin excess
Bradykinin-2 receptor binding on endothelial and vascular smooth muscle cells Hyperpermeability pathway activation, with the transcription of some signalling molecules taking hours Released pro-inflammatory mediators act on venules & arterioles in subcutaneous & submucosa tissues
Relaxation of vascular smooth muscle Dissociation of endothelial cell junctions
↑ Capillary blood flow ↑ Vascular permeability
↑ Plasma release into interstitial tissues (specific regions of the body hypothesized to be affected due to local differences in endothelial structure and its response to permeability inducing stimuli)
Dilation & ↑ permeability of vasculature results in fluid release into surrounding tissues
    Mucosal Layer
Muscularis mucosae
  Submucosal layer
 Muscularis externa
                Intestinal edema (Fluid buildup in Intestine tissues)
Intestinal swelling (↑ intra-abdominal pressure)
Laryngeal edema (Fluid buildup in larynx)
Swelling in larynx ↓ air flow into & out of lungs
Asphyxia (body is deprived of oxygen) Dyspnea (difficult in breathing)
Author: Aaron Varga Reviewers: Tracey Rice Sunawer Aujla Shahab Marzoughi Maharshi Gandhi Jori Hardin* Yan Yu* * MD at time of publication
Peripheral edema (Fluid buildup in extremities such as the hands, ankles, and feet)
       Ascites, bowel obstruction, &/or hypovolemic shock
 Legend:
 Pathophysiology
 Mechanism
Sign/Symptom/Lab Finding
 Complications
 Published Mar 21, 2024 on www.thecalgaryguide.com